Silibinin Inhibits Proliferation, Induces Apoptosis and Causes Cell Cycle Arrest in Human Gastric Cancer MGC803 Cells Via STAT3 Pathway Inhibition

Asian Pacific Journal of Cancer Prevention - Tập 15 Số 16 - Trang 6791-6798 - 2014
Yixin Wang1, Hong Cai, Gang Jiang, Tianbao Zhou, Hai Wu
1Department of Pharmacy, Sichuan Cancer Hospital, Chengdu, China E-mail : [email protected].

Tóm tắt

Từ khóa


Tài liệu tham khảo

2003, Oncogene, 22, 8271, 10.1038/sj.onc.1207158

2012, Carcinogenesis, 33, 2450, 10.1093/carcin/bgs290

1997, Nat Med, 3, 917, 10.1038/nm0897-917

2009, Cancer Cell, 15, 91, 10.1016/j.ccr.2009.01.002

2013, PLoS One, 8, 60320, 10.1371/journal.pone.0060320

2012, Biochem Biophys Res Commun, 417, 874, 10.1016/j.bbrc.2011.12.065

2010, Anticancer Agents Med Chem, 10, 186, 10.2174/1871520611009030186

2013, Food Chem Toxicol, 60, 360, 10.1016/j.fct.2013.07.063

10.7314/APJCP.2012.13.2.633

2010, Cancer Metastasis Rev, 29, 447, 10.1007/s10555-010-9237-0

2006, Oncogene, 25, 1053, 10.1038/sj.onc.1209146

2009, Curr Mol Med, 9, 626, 10.2174/156652409788488720

2008, Blood, 111, 1515, 10.1182/blood-2007-04-087734

2011, Journal of Embryo Transfer, 26, 257

2012, Curr Pharm Biotechnol, 13, 210, 10.2174/138920112798868818

2005, Pharmacol Rev, 57, 187, 10.1124/pr.57.2.6

2011, BMC Cancer, 11, 125, 10.1186/1471-2407-11-125

2013, Nutr Cancer, 65, 590, 10.1080/01635581.2013.770043

2005, CA Cancer J Clin, 55, 178, 10.3322/canjclin.55.3.178

2012, Expert Opin Ther Targets, 16, 889, 10.1517/14728222.2012.709238

2006, Clin Cancer Res, 12, 11, 10.1158/1078-0432.CCR-04-1752

2007, J Surg Res, 143, 58, 10.1016/j.jss.2007.03.080

2012, Carcinogenesis, 33, 1459, 10.1093/carcin/bgs165

2012, Neoplasma, 59, 52, 10.4149/neo_2012_007

2012, Cancer Lett, 315, 198, 10.1016/j.canlet.2011.10.011

2012, Evid Based Complement Alternat Med, 2012, 952762

2007, Apoptosis, 12, 1543, 10.1007/s10495-007-0087-3

2009, Clin Cancer Res, 15, 1126, 10.1158/1078-0432.CCR-08-0144

2013, Dig Surg, 30, 174, 10.1159/000351177

2009, Mol Cancer Ther, 8, 2366, 10.1158/1535-7163.MCT-09-0304

10.7314/APJCP.2013.14.11.6595

2009, J Gastroenterol Hepatol, 24, 646, 10.1111/j.1440-1746.2008.05671.x

2008, J Clin Invest, 118, 3367, 10.1172/JCI35213

2012, Gut Liver, 6, 45, 10.5009/gnl.2012.6.1.45

2008, Lancet Oncol, 9, 279, 10.1016/S1470-2045(08)70072-X

2010, Expert Opin Investig Drugs, 19, 243, 10.1517/13543780903533631

2009, Mol Cancer Ther, 8, 1606, 10.1158/1535-7163.MCT-08-1152

2012, J Agric Food Chem, 60, 12451, 10.1021/jf300964f

2012, Acta Pharmacol Sin, 33, 682, 10.1038/aps.2012.18

2012, Cell Signal, 24, 2291, 10.1016/j.cellsig.2012.07.009

2009, Nat Rev Cancer, 9, 153, 10.1038/nrc2602

10.7314/APJCP.2013.14.6.3449

2011, Mol Biol Cell, 22, 555, 10.1091/mbc.E10-07-0644

2002, Cancer Res, 62, 3351

2013, Nutr Cancer, 65, 3, 10.1080/01635581.2013.785004

2012, Epigenetics, 7, 1161, 10.4161/epi.22070

2010, Mol Carcinog, 49, 247, 10.1002/mc.20595

2000, Int J Oncol, 16, 871

2008, Clin Cancer Res, 14, 5000, 10.1158/1078-0432.CCR-08-0746

2011, Clin Cancer Res, 17, 1452, 10.1158/1078-0432.CCR-10-2694

2002, Oncogene, 21, 2000, 10.1038/sj.onc.1205260

2013, Oncol Rep, 29, 1343, 10.3892/or.2013.2252

2010, Dev Cell, 18, 533, 10.1016/j.devcel.2010.02.013

2001, Curr Med Chem, 8, 1487, 10.2174/0929867013371996

2003, J Biochem Mol Biol, 36, 60, 10.5483/BMBRep.2003.36.1.060

2013, PLoS One, 8, 55183, 10.1371/journal.pone.0055183

2010, Cancer Res, 70, 2368, 10.1158/0008-5472.CAN-09-3249

2006, Front Bio Sci, 11, 1164, 10.2741/1871

2011, Am J Cancer Res, 1, 347

2002, Cell Cycle, 1, 122, 10.4161/cc.1.2.115

2012, Chem Pharm Bull (Tokyo), 60, 1574, 10.1248/cpb.c12-00745

2012, J Recept Signal Transduct Res, 32, 321, 10.3109/10799893.2012.733885

2004, Curr Cancer Drug Targets, 4, 1, 10.2174/1568009043481605

2000, Cell Death Differ, 7, 329, 10.1038/sj.cdd.4400656

2012, Prostate, 72, 82, 10.1002/pros.21409

2001, Oncogene, 20, 1803, 10.1038/sj.onc.1204252

2002, Cell Cycle, 1, 137

2004, Carcinogenesis, 25, 1711, 10.1093/carcin/bgh180

2002, Clin Cancer Res, 8, 3512

2008, Eur J Cancer, 44, 182, 10.1016/j.ejca.2007.11.001

2008, Eur J Cancer, 44, 898, 10.1016/j.ejca.2008.02.020

2012, Mar Drugs, 10, 2055, 10.3390/md10092055

10.7314/APJCP.2013.14.4.2343

2012, J Pathol, 226, 352, 10.1002/path.3022

2009, Acta Pharmacol Sin, 30, 1162, 10.1038/aps.2009.94

2012, J Mol Med (Berl), 90, 1037, 10.1007/s00109-012-0869-0

2007, Int J Oncol, 30, 437

2013, PLoS One, 8, 64159, 10.1371/journal.pone.0064159

10.7314/APJCP.2012.13.4.1377

10.7314/APJCP.2013.14.8.4685

2012, Proc Natl Acad Sci USA, 109, 9623, 10.1073/pnas.1121606109